SUCROFERRIC OXYHYDROXIDE (Velphoro®)

Clinical Indication

Treatment/prevention of hyperphosphataemia of chronic kidney disease

Date of classification

March 2017

Red

Medicines which should be prescribed only in a specialist setting usually within a secondary or tertiary care service. NB: Some highly specialised RED medicines e.g. injectable treatments for cancer are not included on the LLR APC website list.